KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $391.5 million.

  • Resmed's Accumulated Expenses rose 1105.09% to $391.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $391.5 million, marking a year-over-year increase of 1105.09%. This contributed to the annual value of $402.3 million for FY2025, which is 650.69% up from last year.
  • Resmed's Accumulated Expenses amounted to $391.5 million in Q4 2025, which was up 1105.09% from $395.8 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Accumulated Expenses registered a high of $402.3 million during Q2 2025, and its lowest value of $274.1 million during Q3 2021.
  • Its 5-year average for Accumulated Expenses is $345.7 million, with a median of $347.8 million in 2023.
  • Examining YoY changes over the last 5 years, Resmed's Accumulated Expenses showed a top increase of 2954.58% in 2021 and a maximum decrease of 157.38% in 2021.
  • Quarter analysis of 5 years shows Resmed's Accumulated Expenses stood at $286.8 million in 2021, then increased by 8.84% to $312.2 million in 2022, then rose by 6.4% to $332.1 million in 2023, then rose by 6.14% to $352.5 million in 2024, then increased by 11.05% to $391.5 million in 2025.
  • Its Accumulated Expenses was $391.5 million in Q4 2025, compared to $395.8 million in Q3 2025 and $402.3 million in Q2 2025.